Purpose: Recent publications have reported the adverse effects of prostaglandin analogues on the periocular tissues. These medications may cause periorbital lipodystrophy, enophthalmos, and deepening of the superior sulcus deformity. While these effects may have adverse consequences for some patients, the atrophy of the periorbital fat may have a useful role in diseases that lead to orbital and periorbital fat hypertrophy such as thyroid eye disease. In this pilot study, the authors investigated the effects of retrobulbar bimatoprost injection on the intraocular pressure and orbital fat in a rat animal model. Methods: Three rats were sedated and intraocular pressure was measured. A 0.1 ml aliquot of bimatoprost was injected into the right orbit of all rats. In the left orbit, 0.1 ml of phosphate-buffered saline was injected as a control. Three weeks later, all rats were sedated and intraocular pressure was measured before euthanizing. Routine histologic staining was performed and thin sections through the intraconal orbital fat were obtained. Density of intraconal adipocytes was measured and adipocyte heterogeneity was determined using a computer image analysis algorithm. Results: The specimens injected with bimatoprost demonstrated atrophy of orbital fat with significantly increased adipocyte density (p = 0.009) and heterogeneity (p = 0.008) when compared with control. Intraocular pressure was not significantly decreased at 3 weeks after injection of retrobulbar bimatoprost. Conclusions: In this pilot study, orbital injection of bimatoprost demonstrated atrophy of intraconal adipocytes when compared with control orbits injected with saline. The orbits injected with bimatoprost were noted to have smaller, more heterogeneous adipocytes that were densely packed in the intraconal space. The study limitations include the small sample size, which limited the ability for us to make conclusions about the effect on intraocular pressure. Nevertheless, the findings presented suggest that retrobulbar bimatoprost may present a nonsurgical alternative to induce atrophy of the orbital fat without inducing inflammation or hypotony. (C) 2017 by The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc., All rights reserved.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oRQ2BH
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o7K1Dm via IFTTT
-
AP ® United States Government and Politics 2014 Free-Response Questions © 2014 The College Board. College Board, Advanced Placement Program,...
-
You know the feeling: you're hanging out somewhere, you look across the room, and suddenly your stomach drops. You start to sweat. Your ...
-
Unit 5: Writing cohesively - Section index. This unit looks at the use of language strategies to create clear, cohesive writing. It shows yo...
-
Introduction Crisis management is a critical organizational function. Failure can result in serious harm to stakeholders, losses for an orga...
-
918 quotes have been tagged as self-confidence: Edgar Allan Poe: ‘I have great faith in fools - self-confidence my friends will call it.’, R...
-
Abstract This randomized and longitudinal in vivo study aimed to assess different protocols for the treatment of dentin hypersensitivity w...
-
About IRF. The Incentive Research Foundation (IRF), a private not-for-profit foundation, funds research studies and develops products servin...
-
9781421620831 1421620839 Coral Reef 2008 Square Wall - Wall 9780160782732 0160782732 Code of Federal Regulations, Title 27, Alcohol, Tobacco...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου